B&S Group (BSGR) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
23 Nov, 2025Executive summary
Turnover increased 4.5% year-over-year to €1,119.6M, with organic growth led by Beauty, Personal Care, and Food segments, and gross profit up 4.2% to €167.3M.
Net profit from continuing operations was €14.5M, while total net profit including discontinued operations rose to €40.7M, driven by the Health segment divestment.
Operational excellence, improved working capital, and a global HR and sustainability agenda underpinned performance.
Acquisition of Tastemakers Holding B.V. and remaining stakes in Personal Care and B&S HTG B.V. supported segment growth.
Strategic focus remains on digitisation, sustainability, and segment autonomy.
Financial highlights
Turnover grew 4.5% to €1.1B; gross profit margin stable at 14.9% year-over-year.
Normalized EBITDA margin declined to 4.4%–4.2%; normalized EBITDA at €49.5M, down from €52.3M.
Net profit from continuing operations at €14.5M; total net profit including discontinued operations at €40.7M.
Positive operating cash flow of €9.5M, a significant improvement from a €44M outflow last year.
EPS including discontinued operations increased to €0.37 from €0.16.
Outlook and guidance
Topline growth expected to continue at approximately 5% for 2025, excluding divested revenue.
Staff costs anticipated to keep rising in line with H1 trends and market developments.
Normalized EBITDA margin expected at the lower end of the communicated 2024–2026 financial objectives.
Segment diversification expected to provide group stability.
Liquors topline to remain lower due to strategic changes; Travel Retail to grow in existing locations but offset by prior closures.
Latest events from B&S Group
- Turnover and profit rose, but higher debt and inventory prompt focus on working capital.BSGR
H1 20241 Feb 2026 - Q3 sales up 11.8% year-over-year; gross margin pressured, EBITDA margin at lower end of guidance.BSGR
Q3 2024 TU15 Jan 2026 - Turnover up 8.9% to €2.4B, EBITDA up 12.9%, 2025 outlook: 5% growth, 5–6% margin.BSGR
Q4 20242 Dec 2025 - Q1 revenue up 4%–5.3% to €570M, but margin guidance withheld amid global uncertainty.BSGR
Q1 2025 TU24 Nov 2025 - 9M turnover up 2.4%, Q3 gross margin improved, outlook projects 5% topline growth.BSGR
Q3 2025 TU11 Nov 2025